Published in Endocr Connect on February 21, 2017
The Role of Vitamin D in Thyroid Diseases. Int J Mol Sci (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (2009) 67.17
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer (2007) 6.18
Integrated genomic characterization of papillary thyroid carcinoma. Cell (2014) 6.05
Genetics and biology of vitamin D receptor polymorphisms. Gene (2004) 4.60
Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab (2001) 4.47
The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res (1998) 4.27
The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer (2014) 2.41
How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) (2008) 2.19
The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res (2009) 1.90
Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol (2008) 1.85
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab (1997) 1.79
Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet (1989) 1.36
Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers. J Clin Endocrinol Metab (2009) 1.32
Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem Mol Biol (2005) 1.28
Vitamin D and cancer. J Cancer Res Ther (2008) 1.17
Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089. Clin Cancer Res (2005) 1.16
Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat (1994) 1.09
1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Mol Cancer Ther (2008) 0.96
Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. Steroids (2001) 0.96
The role of vitamin D in cancer prevention and treatment. Rheum Dis Clin North Am (2012) 0.90
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas. Onco Targets Ther (2015) 0.88
Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism. Thyroid (2010) 0.87
Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors. J Histochem Cytochem (2012) 0.85
Vitamin D receptor expression is linked to potential markers of human thyroid papillary carcinoma. J Steroid Biochem Mol Biol (2016) 0.82
Calcitriol inhibits the growth of MHCC97 heptocellular cell lines by down-modulating c-met and ERK expressions. Liver Int (2007) 0.80
Plasma 25-hydroxyvitamin D and risk of colorectal cancer after adjusting for inflammatory markers. Cancer Epidemiol Biomarkers Prev (2014) 0.80